Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.

Authors :: Tisdale JF
Pierciey FJ Jr
Bonner M
Thompson AA
Krishnamurti L
Mapara MY
Kwiatkowski JL
Shestopalov I
Ribeil JA
Huang W
Asmal M
Kanter J
Walters MC
Source :: American journal of hematology [Am J Hematol] 2020 Sep; Vol. 95 (9), pp. E239-E242. Date of Electronic Publication: 2020 Jun 03.
Publication Year :: 2020

Subjects :: Adult
Anemia, Sickle Cell blood
Anemia, Sickle Cell genetics
Anemia, Sickle Cell metabolism
Autografts
Benzylamines
Cyclams
Female
Heterocyclic Compounds adverse effects
Humans
Male
Middle Aged
Anemia, Sickle Cell therapy
Blood Component Removal
Bone Marrow
Genetic Therapy
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation
Heterocyclic Compounds administration & dosage

Full Text Access

Tools